This biotech specializes in precision therapies for rare genetic diseases, with a pipeline targeting oncology and hematology ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Biotech and drug-innovation themes continue to dominate markets—from AI-driven drug discovery to blockbuster obesity treatments—and a new ETF filing suggests asset managers want a piece of that ...

Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some ...

Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many ...

Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...

Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, ...

Vertex's CF drugs are bringing in billions of dollars in revenue, and in recent years the company has also expanded into ...

Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...

China’s biopharmaceutical and biotechnology companies are rapidly expanding their global presence, driven not only by strong ...